EUVIMEDEUVIMED entdecken
Open Access

Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve

Lucy Joanne Kessler, Gerd Uwe Auffarth, Ramin Khoramnia

Journal of Ocular Pharmacology and Therapeutics · 2023

DOI: 10.1089/jop.2023.0027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2023. Verfasst von Lucy Joanne Kessler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Macular Edema, Uveitis, Diabetic Retinopathy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigated the impact of baseline clinical and optical coherence tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) implant in patients with noninfectious uveitic macular edema evaluated by the area under the curve over 24 months.

Methods

A retrospective study was conducted of eyes of patients with noninfectious uveitic macular edema undergoing FAc treatment, with follow-up from baseline to 24 months. The area under the curve (AUC) of best-corrected visual acuity (BCVA) and the central macular thickness (CMT) were calculated using the trapezoidal rule. Clinical and OCT data at the time of FAc administration were collected, and associations with AUC of BCVA and CMT changes were investigated.

Results

Twenty-three patients were enrolled. BCVA and CMT significantly improved after FAc implantation (P 0.05). The younger the patient at the time of FAc injection, the greater the reduction in CMT (coef. = 1.76, P < 0.05).

Conclusions

Among all clinical and morphological baseline factors, Baseline BCVA was the strongest predictor for AUCBCVA, while no association with baseline OCT features was observed. Overall, improvement of BCVA and CMT after FAc injection was maintained over 24 months. This study is registered in the German Clinical Trials Register under the DRKS-ID: DRKS00024399.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaUveitisDiabetic RetinopathyHumansGlucocorticoidsRetrospective StudiesVisual AcuityFluocinolone AcetonideIntravitreal InjectionsTomography, Optical CoherenceDrug Implants

Stichwörter der Autor:innen

drug responsefluocinolone acetonidemacular edemaocular implantoptical coherence tomography biomarkersuveitis

Substanzen

GlucocorticoidsFluocinolone AcetonideDrug Implants

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.

Zitieren

APA

Kessler, L. J., Auffarth, G. U., & Khoramnia, R. (2023). Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0027

Vancouver

Kessler LJ, Auffarth GU, Khoramnia R. Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. Journal of Ocular Pharmacology and Therapeutics. 2023. doi:10.1089/jop.2023.0027

BibTeX
@article{Kessler2023,
  author = {Kessler, Lucy Joanne and Auffarth, Gerd Uwe and Khoramnia, Ramin},
  title = {Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2023},
  doi = {10.1089/jop.2023.0027}
}
Kostenlos starten →